| 发明名称 |
INHIBITOR OF JAK1 AND JAK2 |
| 摘要 |
The present invention provides an amino pyrazole compound, which is 3-[(1R)-6-fluoro-2,3-dihydro-1H-inden-1-yl]-N-(3-methyl-1H-pyrazol-5-yl)-3H-imidazo[4,5-b]pyridin-5-amine, or a pharmaceutically acceptable salt thereof, that inhibits JAK1 and JAK2 and, therefore may be useful in treating cancer. |
| 申请公布号 |
US2015133490(A1) |
申请公布日期 |
2015.05.14 |
| 申请号 |
US201314402146 |
申请日期 |
2013.06.05 |
| 申请人 |
Eli Lilly and Company |
发明人 |
Burkholder Timothy Paul;Clayton Joshua Ryan |
| 分类号 |
C07D471/04 |
主分类号 |
C07D471/04 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A compound which is 3-[(1R)-6-fluoro-2,3-dihydro-1H-inden-1-yl]-N-(3-methyl-1H-pyrazol-5-yl)-3H-imidazo[4,5-b]pyridin-5-amine, or a pharmaceutically acceptable salt thereof. |
| 地址 |
Indianapolis IN US |
